Skip to main content
Home Licenses Page 2

Have Questions?

Please contact us or subscribe for more opportunities

Stay in Touch with Us

https://otc.duke.edu/wp-content/uploads/2024/06/DukeMag_Summer24_science_nim_5.jpg

Meta Marketplace – Duke Magazine

Ideas from the lab of David Smith (ECE, Pratt) are showing up all over the place. Learn more about the lab's multiple spinouts.

Read More

https://otc.duke.edu/wp-content/uploads/2024/06/Weird-Science-illustration.png

Weird Science – Duke Magazine

Professor David Smith (ECE, Pratt) is a pioneer in the field of metamaterials – melding basic research and successful commercialization.

Read More

https://otc.duke.edu/wp-content/uploads/2024/06/amgen_logo.jpg

AMGEN ANNOUNCES POSITIVE RESULTS FOR PHASE 3 REGISTRATIONAL TRIAL EVALUATING UPLIZNA® (INEBILIZUMAB-CDON) FOR TREATMENT OF IMMUNOGLOBULIN G4-RELATED DISEASE (IgG4-RD)

Uplizna, an antibody therapy for immune diseases, is based on technology licensed from Duke University, developed by the late Dr. Thomas Tedder (Immunology, SOM) and colleagues.

Read More

https://otc.duke.edu/wp-content/uploads/2024/06/restor3d_sign.jpg

restor3d Announces Successful Closing of $70 Million Financing

restor3d is a Duke orthopedic medical device start-up spun out of the lab of Professor Ken Gall (MEMS, Pratt). DCP has participated in every round.

Read More

https://otc.duke.edu/wp-content/uploads/2024/05/davinci-merger-featured-image.png

Better Together: Elentra and DaVinci Education Combine to Drive Transformation in Healthcare Education

DaVinci Education is a Duke University start-up, spun out around technology developed by David Wiener, Colleen Grochowski, and Vice Dean Dr. Edward Buckley (Ophthalmology, SOM).

Read More

https://otc.duke.edu/wp-content/uploads/2024/05/Piximune-logo.png

ARVO recognizes Daniel R. Saban as a rising star in the world of ophthalmology and visual science

Leading research organization awards Associate Professor Daniel R. Saban (Ophthalmology, SOM) for his contributions to the field. Saban is commercializing this research through Duke University start-up Piximune Therapeutics.

Read More

https://otc.duke.edu/wp-content/uploads/2024/04/LumiSystem_Family_withoutLogo_v5-1000.jpg

Lumicell’s Cutting-Edge Imaging Platform Receives Historic FDA Approval to Illuminate Residual Breast Cancer

Lumicell is an MIT start-up based on breast cancer imaging technology co-developed by Dr. David Kirsch (Radiation Oncology, SOM).

Read More

https://otc.duke.edu/wp-content/uploads/2024/04/plug-and-play-logo.png

Plug and Play Announces Inaugural Batch of Startups Selected for their Medtech Program

Duke start-up Sparta Biomedical has been selected for Batch 1 of Plug and Play's Warsaw Medtech program in Spring 2024.

Read More

https://otc.duke.edu/wp-content/uploads/2023/10/BMI_OrganBank_Logo.jpg

BMI OrganBank, Atrium Health and LifeShare Carolinas Partner to Launch Nation’s First Organ Banking Technology

BMI OrganBank licensed perfusion tech from the Duke Ex-Vivo Organ Lab, led by Drs. Andrew S. Barbas and Matthew Hartwig (Surgery, SOM).

Read More